POLYMYALGIA RHEUMATICA
Clinical trials for POLYMYALGIA RHEUMATICA explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New IV treatment explored for painful inflammatory conditions
Disease control CompletedThis study looked at how an intravenous (IV) form of secukinumab is processed by the body and whether it is safe for adults with giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). These conditions cause inflammation in blood vessels or muscles, leading to pain and stiffn…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New hope for PMR patients: drug may reduce need for steroids
Disease control CompletedThis study tested whether rituximab, a drug that calms the immune system, can help people with polymyalgia rheumatica (PMR) stop taking steroids sooner. PMR causes pain and stiffness, and steroids are the main treatment but have side effects. The trial included 114 newly diagnose…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Sint Maartenskliniek • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
New hope for PMR patients: drug may replace long-term steroids
Disease control CompletedThis study tested two doses of secukinumab (a shot) combined with a steroid taper in 381 adults aged 50+ with polymyalgia rheumatica (PMR) who had recently relapsed. The goal was to see if secukinumab helps patients achieve and maintain remission without needing steroids long-ter…
Matched conditions: POLYMYALGIA RHEUMATICA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC
-
New study links common arthritis treatments to diabetes risk
Knowledge-focused CompletedThis observational study followed 198 adults aged 50–85 with giant cell arteritis or polymyalgia rheumatica to understand how common treatments (glucocorticoids and interleukin-6 inhibitors) affect diabetes risk. Researchers tracked blood sugar levels and other markers over time.…
Matched conditions: POLYMYALGIA RHEUMATICA
Sponsor: Salome Kristensen • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC